TRIM55 assumes a paramount function in suppressing the progression of HCC partially through the degradation of NF90 and the subsequent inactivation of its downstream pathway, encompassing HIF1α/VEGF and TGFβ/Smad signaling. This evidence concerns the gene TGFB1 and hepatocellular carcinoma.